Showing results (31-40 of 152) with videos related to
Sort By:
Pageof 16
Journal of Neurochemistry|September 22, 2007
Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase responseSandra J Campbell, Yanyan Jiang, Andrew E M Davis, et al.Multiple Sclerosis and Related Disorders|April 9, 2023
High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseasesAmin Ziaei, Zahra Nasr, Janace Hart, et al.Frontiers in Neurology|July 1, 2022
A Method to Combine Neurofilament Light Measurements From Blood Serum and Plasma in Clinical and Population-Based StudiesNicole Rübsamen, Eline A J Willemse, David Leppert, et al.Therapeutic Advances in Neurological Disorders|April 1, 2024
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a <i>post hoc</i> analysisJens Kuhle, David Leppert, Giancarlo Comi, et al.Neurology|April 5, 2022
Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled TrialsDavid Leppert, Harald Kropshofer, Dieter A Häring, et al.Journal of Neuroimmunology|June 30, 2004
Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MSRaija L P Lindberg, Corline J A De Groot, Ulrich Certa, et al.Annals of Clinical and Translational Neurology|June 19, 2019
Blood neurofilament light as a potential endpoint in Phase 2 studies in MSMaria Pia Sormani, Dieter A Haering, Harald Kropshofer, et al.BMC Biology|June 6, 2006
Gene expression in cortex and hippocampus during acute pneumococcal meningitisRoney S Coimbra, Veronique Voisin, Antoine B de Saizieu, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Long-term prognostic value of longitudinal measurements of blood neurofilament levelsDieter A Häring, Harald Kropshofer, Ludwig Kappos, et al.Cancer|May 27, 2003
Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinomaPaul N Span, C G J Sweep, Peggy Manders, et al.Pageof 16